Both in Biotechnology
INmune Bio vs eXoZymes
Over the past year INMB returned −17.4% and EXOZ returned −69.3%; their daily moves had a correlation of 0.15.
INMB −17.4% EXOZ −69.3%Growth of $1, one year, split-adjusted
| Metric | INMB | EXOZ |
|---|---|---|
| Price | $1.52 | $3.80 |
| Market cap | $42.2M | $35.4M |
| Today | +6.29% | +1.33% |
| 1 month | −24.0% | −36.7% |
| 6 months | +8.6% | −63.2% |
| Year to date | −2.6% | −65.1% |
| 1 year | −20.0% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $18.4M | $5.6M |
| Dividend yield | — | — |
| Volatility (60d) | 64.0% | 76.7% |
| Short % of float | 11.7% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).